Chronic inflammatory demyelinating polyneuropathy (CIDP) is the most common form of
autoimmune polyneuropathy. It is a chronic disease and may be monophasic, progressive or …

Aim The availability of disease-modifying therapies and newborn screening programs for
spinal muscular atrophy (SMA) has generated an urgent need for reliable prognostic …

Background: Neurodegenerative disorders may depend upon a misregulation of the
pathways which sustain neurodevelopmental control. In this context, this review article …

Alzheimer's disease is an insidious and progressive loss of balance and cognitive memories
from present time to distant past that occurs in reverse chronological order. While the cause …

Few studies examined blood biomarkers informative of patient-reported outcome (PRO) of
disability in people with multiple sclerosis (MS). We examined the associations between …

Background Autoimmune nodopathy (AN) has emerged as a novel diagnostic category that
is pathologically different from classic chronic inflammatory demyelinating polyneuropathy …

Clemastine (CLM) is repurposed to enhance remyelination in multiple sclerosis (MS)
patients. CLM blocks histamine and muscarinic receptors as negative regulators to …

Neonatal encephalopathy (NE) impairs white matter development and results in long-term
neurodevelopmental deficits. Leveraging prior findings of altered neuronal proteins carried …

Background The most frequent kind of dementia in the senior population is Alzheimer's
disease (AD). Antioxidant quercetin has a low bioavailability. The bioavailability of quercetin …

BACKGROUND: Anti-CNTN-1 autoimmune nodopathies (AN) is a new and rare diagnosis of
peripheral neuropathy proposed by the European Society of Neurology in recent years …